Q1 2025 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2025-05-12 · accession 0001172661-25-001685
$385.1M
Reported value
20
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04016X101 | ARGX | ARGENX SE | $44.4M | 11.5% | 74,990 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $39.6M | 10.3% | 279,764 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $36.6M | 9.51% | 209,190 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $33.8M | 8.78% | 443,300 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $27.2M | 7.07% | 343,361 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $27.0M | 7.02% | 382,612 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $24.9M | 6.46% | 225,100 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $24.4M | 6.33% | 356,921 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $22.7M | 5.90% | 627,600 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $17.7M | 4.60% | 65,656 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $17.4M | 4.52% | 299,089 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $16.8M | 4.37% | 388,650 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $12.9M | 3.36% | 81,121 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $9.7M | 2.52% | 330,830 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $9.2M | 2.38% | 226,400 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $8.8M | 2.29% | 56,500 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $6.8M | 1.76% | 100,661 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $2.2M | 0.56% | 4,390 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.6M | 0.40% | 240,500 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.4M | 0.36% | 46,300 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.